Alvotech (ALVO) Change in Intangibles (2022 - 2026)
Alvotech (ALVO) posted Change in Intangibles of -$39.1 million for Q1 2026, down 312.65% on a QoQ basis from -$9.5 million in Q3 2025, and down 21240.44% year-over-year from N/an in Q1 2025.
Alvotech (ALVO) Change in Intangibles (2022 - 2026) Analysis & Trends
Alvotech's Change in Intangibles history runs 5 years deep, the most recent figure standing at -$39.1 million for Q1 2026.
- Quarterly Change in Intangibles fell 21240.44% year-over-year to -$39.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$63.7 million (down 1216.89% YoY) and the FY2021 annual result came in at -$20.2 million, down 348.54% from the prior year.
- Change in Intangibles was -$39.1 million for Q1 2026 at Alvotech, down from -$9.5 million in the prior quarter.
- Across five years, Change in Intangibles topped out at -$183000.0 in Q1 2025 and bottomed at -$39.1 million in Q1 2026.
- A 5-year average of -$8.0 million and a median of -$2.9 million in 2023 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2024 — Change in Intangibles soared 78.69% — and 2026, when it tumbled 21240.44%.
- Alvotech's Change in Intangibles stood at -$11.1 million in 2022, then retreated by 19.03% to -$13.2 million in 2023, then surged by 74.78% to -$3.3 million in 2024, then tumbled by 183.44% to -$9.5 million in 2025, then sank by 312.65% to -$39.1 million in 2026.
- Business Quant data shows ALVO's Change in Intangibles at -$39.1 million in Q1 2026, -$9.5 million in Q3 2025, and -$15.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -107.94 Mn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn | - |
| 10 | Alvotech | 915.27 Mn | 915.27 Mn | 5.09 Mn | -39.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.05 Mn |
| Mar 31, 2026 | -39.05 Mn |
| Sep 30, 2025 | -9.46 Mn |
| Sep 30, 2025 | -9.46 Mn |
| Jun 30, 2025 | -14.99 Mn |
| Jun 30, 2025 | -14.99 Mn |
| Mar 31, 2025 | -183,000.00 |
| Mar 31, 2025 | -183,000.00 |
| Dec 31, 2024 | -3.34 Mn |
| Dec 31, 2024 | -3.34 Mn |
| Sep 30, 2024 | -427,000.00 |
| Sep 30, 2024 | -427,000.00 |
| Jun 30, 2024 | -887,000.00 |
| Jun 30, 2024 | -887,000.00 |
| Mar 31, 2024 | -543,000.00 |
| Mar 31, 2024 | -543,000.00 |
| Dec 31, 2023 | -13.24 Mn |
| Dec 31, 2023 | -13.24 Mn |
| Jun 30, 2023 | -216,000.00 |
| Jun 30, 2023 | -216,000.00 |